Menopausal Hormonal Shifts Drive Dry Eye Epidemic, Prompting Call for Routine Screening
Dry eye syndrome affects up to 80% of menopausal women due to hormonal drops that destabilize the tear film. Recent research urges clinicians to include dry eye in standard menopause checklists, as symptoms often worsen post-menopause. While intentional blinking and supplements offer relief, experts emphasize that the condition is chronic and requires long-term management, with treatment ranging from preservative-free drops to in-office procedures.
Key points
- Hormonal declines in estrogen, progesterone, and testosterone disrupt meibomian gland function, reducing oil production and causing tears to evaporate rapidly.
- Researchers at George Washington University presented a framework at The Menopause Society 2026 meeting, arguing dry eye should be added to standard menopause symptom checklists.
- A study of 1,947 women found 79% experienced dry eye symptoms, with postmenopausal women reporting higher severity than perimenopausal women.
- Treatment options include preservative-free artificial tears, warm compresses, and supplements containing lutein and curcuminoids, though systemic hormone therapy is not recommended solely for dry eye.
- Experts warn that untreated dry eye can lead to corneal abrasions and scarring, emphasizing the need for early diagnosis and long-term management.
Background
Dry eye has long been recognized as a common ocular issue, but its specific link to the menopausal transition has gained recent clinical attention. Previous discussions often treated it as an isolated symptom rather than a core component of menopause. The current shift focuses on integrating ocular health into broader hormonal care frameworks, moving away from reactive treatment toward proactive screening.
How outlets are covering it
Prevention highlights personal experiences with intentional blinking and supplements, suggesting these simple habits can mitigate symptoms. In contrast, Medscape and the Sacramento Bee emphasize the clinical urgency, citing data that 64-80% of menopausal women suffer from the condition and urging formal inclusion in medical guidelines. Insight News focuses on the chronic nature of the disease, stressing that dry eye is a long-term condition requiring consistent management with hyaluronate-based products, rather than a short-term fix. While Prevention focuses on lifestyle adjustments, the medical sources stress the need for professional diagnosis and potential referral to specialists for severe cases.
Why it matters
Recognizing dry eye as a standard menopause symptom could improve quality of life for millions of women by ensuring earlier intervention. It shifts the conversation from managing isolated eye discomfort to addressing a systemic hormonal impact, potentially preventing long-term vision issues and reducing the burden on healthcare systems through better preventive care.
What to watch
Clinicians are expected to adopt the six-item Ocular Surface Disease Index for routine screening. Patients may see increased access to specialized treatments like thermal pulsation or IPL therapy. Further prospective studies are needed to validate the proposed clinical frameworks and determine the efficacy of specific hormone therapies in managing ocular symptoms.
- At 59, My Eyes Were Dry, Gritty, and Constantly Watering—Until I Tried This Simple, Doctor-Approved Trick Prevention
- Dry eye is common among menopausal women. Here’s how to spot symptoms and when to see a doctor Sacramento Bee
- Researchers Urge Adding Dry Eye Treatment to Menopause Care Medscape
- Dry eye care is long-term Insight News
- What causes dry eye and what can be done to prevent it? UCLA Health
Want the full story? Read the original reporting
Read on Prevention